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Abstract  
 
Endogenous opioids have been implicated in mediating (placebo) analgesia, in reward 
processes and in the regulation of socially relevant emotions. To explore their potential 
contribution to higher cognitive functions, we used a novel task with tachistoscopically 
(150ms) presented pairs of meaningless figures. Healthy right-handed men judged the 
similarities and dissimilarities between the two figures on a visual analogue scale (VAS) in 
two separate runs. In a double-blind, between-subject design, participants were 
administered either 0.2 mg/kg naloxone intravenously or placebo 10 minutes prior to the 
task. VAS judgments and response latencies were measured. There was a significant 
interaction between substance group and type of judgment; the magnitude of similarity 
judgments was lower in the naloxone than in the placebo group, while dissimilarity 
judgments remained uninfluenced by the treatment. Reaction latencies and mood scores, 
assessed before and after substance administration, did not differ between the two groups, 
indicating that the findings do not rely on altered motor performance or motivation. We infer 
that naloxone decreased the “similarity criterion” in comparative judgments, indicating its 
modulatory effect on visual cognition. The task introduced here could be used for the implicit 
study and quantification of subtle affective-cognitive processes beyond the level of mere 
questionnaire data.  
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Introduction 
 
Endogenous opioid systems have mainly been implicated in affective processes such as the 
response to reward (Smith and Berridge, 2007), the modulation of endocrine functions (e.g. 
Drolet et al., 2001), the regulation of affect (e.g. Zubieta et al., 2003), pleasure-related 
analgesia (Leknes and Tracey, 2008, Kut et al., 2011) and the mediation of (placebo) 
analgesia (e.g. Petrovic et al., 2002). Moreover, several lines of evidence indicate that the 
neurocircuitry and neurochemistry of physical pain overlap with those of more abstract, 
complex cognitive-affective experiences such as social emotions (Macdonald and Leary, 
2005, Stein et al., 2007), in particular social attachment (Herman and Panksepp, 1978, 
Panksepp et al., 1980, Moles et al., 2004, Barr et al., 2008). In a recent neuroimaging study 
with healthy subjects, Eisenberger et al. (2003) showed that neural networks activated 
during distress caused by social exclusion are also activated during physical pain and that 
pain experience can be reduced by visual stimuli signalling attachment (Eisenberger et al., 
2011). In line with these findings of “social distance regulation” is the general explanation for 
the feeling of physical pain that accompanies emotional loss (Panksepp, 2003), whether it be 
the loss of a loved one (Zubieta et al., 2003), rejection by one's social group (Eisenberger et 
al., 2003, Eisenberger et al., 2006), or the distress experienced by young animals when 
being separated from their parents (Panksepp, 1998). 
In healthy humans, opioid agonists have been implicated in feelings of emotional 
relatedness or social emotions and in mood-elevating effects (Schaffer et al., 2007, Gospic 
et al., 2008, Koepp et al., 2009). By contrast, the mu-opioid antagonist naloxone has been 
shown to influence endocrine functions (Drolet et al., 2001) and occasionally reported to 
induce dysphoric mood states at doses over 0.25 mg/kg (Mendelson et al., 1978, Grevert et 
al., 1983, Martin del Campo et al., 1992, Martin del Campo et al., 1994). However, it remains 
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to be established in how far discrepancies in study findings may be a consequence of the 
lack of a reliable measure and methodological difficulties.  
Most surprisingly, beside reported opioidergically modulated mood effects, only a few 
studies have so far investigated influences on other higher brain functions such as naloxone-
dependent alterations in attention (Buchsbaum et al., 1982, Arnsten et al., 1983, Arnsten et 
al., 1984) and memory (Cohen et al., 1983, Kamboj et al., 2005, Friswell et al., 2008). More 
recently, Biederman and colleagues suggested that mu-opioids are involved in perceptual 
pleasure (Biederman and Vessel, 2006, Yue et al., 2007). However, their influence on 
cognitive judgmental processes is largely unexplored. Endogenous opioids’ influence on 
cognitive functioning is thus of central importance for both, basic and clinical research (Ersek 
et al., 2004 for a clinical review). 
 
From a phenomenological perspective, a cognitive equivalent to emotional feelings of 
relatedness, or more broadly “social emotions”, could be conceptualized as "coherence 
perception" or distance regulation. Judgments of similarity/dissimilarity are an important, 
often neglected, component in a variety of cognitive processes, including object recognition 
(Barenholtz and Tarr, 2008), semantic and perceptual categorization (Pettigrew, 1958), 
esthetics (Wertheimer, 1923/1958), and analogic reasoning (Novick, 1988) and belief 
formation (Gianotti et al., 2001). Spotting similarity has also been proposed to be a 
fundamental aspect of various cognitive processes such as making inferences, knowledge 
generalization, and knowledge transfer (e.g. Gentner et al., 1993).  
 
Although the question of how people judge similarity and dissimilarity is clearly of 
critical importance in social cognition (e.g. Mitchell et al., 2006) and in cognitive psychology, 
little is known about its neurochemical underpinnings and whether it can be considered a 
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distinct cognitive system. We here introduce a novel judgment task assessing “cognitive 
relatedness” or formal visual coherence/contrast perception. In a visual perceptual task 
stimulating cognitive judgments of visual similarity and dissimilarity we investigated whether 
a mu-opioid receptor antagonist (naloxone) could modify healthy subjects’ judgments of 
similarity/dissimilarity. We predicted decreased similarity (coherence perception) and 
increased dissimilarity (contrast perception) judgments in participants receiving a naloxone 
injection. Moreover, we hypothesized a dissociation of similarity and dissimilarity, i.e. we 
assumed that they would not represent two endpoints on a bipolar scale, but instead provide 
two independent, context-related frames of reference. 
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Material and Methods 
 
Subjects:  
Volunteers were 21 advertisement-recruited healthy right-handed men (mean handedness 
score (Chapman and Chapman, 1987) = 13.9, SD = 1.6, range = 13 – 19), 19 – 44 years of 
age (mean = 26.7, SD = 7.4). All subjects gave written informed consent to the experimental 
procedures, which had been approved by the local ethics committee. 
Health status of the participants was assessed with a detailed questionnaire (Campbell, 
2000). All subjects confirmed the absence of any relevant acute or chronic disease 
(hypertension, heart disease, renal disease, liver disease, mental illness, or seizure 
disorder), a history of neurological disorder, a mental illness or mental impairment. 
Participants also denied having a history of abuse of medications, drugs or alcohol and any 
recreational consumption of drugs, narcotics or other CNS-relevant substances over the last 
three months. Participation in the study paid 50 Swiss francs. 
  Participants were tested individually. They were seated on a comfortable 
reclining chair in front of a 15.2 – inch (diagonal) computer screen. Room lighting and screen 
contrast were all kept constant. 
Presentation of all instructions was carried out via computer display and automatically 
controlled by “Superlab Pro 4” (Cedrus) running on an Apple G4 Powerbook,. Distance 
between head and computer screen was adjusted to permit undisturbed view and was kept 
at approximately 60 cm for all participants. 
 
Questionnaire 
Measurement of participants’ mood: Participants rated their mood two times, once at the 
beginning and once at the end of the experiment. Ratings were assessed with 24 adjectives 
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from the German mood questionnaire Multidimensional Mood questionnaire (MDBF) (1997)). 
The MDBF questionnaire is a short, multidimensional, self-evaluative questionnaire that 
describes the current mood state of an individual on three dimensions “good vs. bad mood,” 
“wakefulness vs. sleepiness,” and “calmness vs. restlessness.”  
 
Judgment tasks  
Similarity and dissimilarity judgment tasks. Eighteen different stimulus pairs consisting of 
two horizontally placed meaningless geometric figures were tachistoscopically presented 
(exposure time = 150 ms). One figure of a pair was presented to the left, and the other to the 
right side of a central fixation cross (horizontal eccentricity = 1.5° to 3.0° of visual angle). The 
single pairs were constructed respecting the Gestalt laws of proximity, good continuation, 
closure, similarity, and figure/ground properties. Each stimulus pair was also presented in a 
vertically mirrored version. There were two counterbalanced runs consisting of 36 trials; in 
one subjects had to indicate similarity (SJ: similarity judgment) and in the other dissimilarity 
(DJ: dissimilarity judgment) with a computer mouse in their right hand on a 9-inch bipolar 
visual analogue scale (VAS) presented against a light gray background (Figure 1). All 
objects (object size: within 2.8 x 2.8 cm, lines thickness: 2 point) were printed in black and 
presented on a computer screen (gray background). Sample stimuli are illustrated in Fig.1. 
Stimulus pairs were identical in both the SJ and DJ runs, but presented in a different, 
pseudorandomized order. 
Participants were asked to rest their head on a chin rest, and to fixate the cross in the centre 
of the screen during stimulus exposure. They were instructed to respond as quickly and 
intuitively as possible and were told that their preference ratings on similarity/dissimilarity 
judgments were highly subjective and that there were neither false nor correct judgments. 
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--------------------------------- INSERT FIGURE 1 ABOUT HERE ------------------------------------ 
 
Double–blind procedure 
Naloxone administration. The study had a randomized, double-blind, placebo-controlled, 
between-subject design. Naloxone hydrochloride (n = 10, 0.2 mg / kg bodyweight, 
concentration 1mg/ml, pharmacy of the Kanton Zürich) or the equivalent volume of NaCl (n = 
9, 0.9 %, pharmacy of the Kanton Zürich), respectively was administered. Similar naloxone 
dosages have been previously shown to completely antagonize endogenous opioid-
mediated analgesia in healthy volunteers (Amanzio and Benedetti, 1999). To prevent high 
stress levels during the experiment, a nurse laid an intravenous catheter at the inner elbow 
of the non-dominant arm 10 minutes prior to task administration. The entire testing was 
supervised by a medical doctor. All participants had been asked to refrain from any alcohol, 
caffeine- or taurin-containing beverage for at least 12 hours before the start of the 
experiment and confirmed their compliance in the debriefing. At the end of behavioral 
testing, participants were asked (by questionnaire) which substance they thought they had 
received. 
 
Data analysis 
Two separate two-way ANOVAs with substance group (naloxone vs. placebo) as between-
subject factors, and run (similarity vs. dissimilarity rating) as repeated measures were 
calculated for the position on the VAS (VAS-magnitude in percent) and reaction latencies.  
Homogeneity of variances was checked using Levene’s test (F = 1.775, p = .149); and 
normal distribution of the dependent variables was tested by the Kolmogorov-Smirnov test (Z 
≤ .732, p ≥ .657). If not otherwise stated, tests are two-tailed with an alpha-level at 0.05.  
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Outlier detection was performed by the Grubb-Test. To test for a naloxone influence on 
psychometrically assessed mood, a three-way repeated measure ANOVA was computed 
comprising the between-subject factor substance (naloxone vs. placebo), and the within-
subject factors time (beginning vs. end of the experiment) and mood dimension (valence, 
wakefulness, calmness).  
 
Two subjects did not adhere to the judgment task instruction and constantly pressed the 
keyboard instead of using the mouse to indicate the degree of similarity or dissimilarity on 
the VAS. Valid data were thus available from 19 participants.  
 
Results 
 
Handedness, Age and Blinding 
Participants in the naloxone and placebo group did not differ from one another in age (t(17) = 
-1.72, p = .11) and the strength of right-handedness (t(17) = 1.78, p = .112). 
There was no association between what substance participants believed they had received 
(drug or placebo) and what they had actually received, which suggests that blinding was 
effective (χ2 = 0.259 p = .611): eighty-four percent of the study participants believed they 
had received saline. Two participants who thought they had received naloxone were in the 
placebo group and one participant under the influence of naloxone correctly detected the 
substance.  
 
 
Questionnaires 
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Mood ratings (MDBF) assessed at the beginning and the end of the experiment did not differ 
significantly from each other nor were there any interactions with substance type (all F-
values ≤ 2.241, corresponding p-values ≥ .122). 
 
Cognitive Judgment Tasks  
No significant main effects were found for VAS magnitudes (all F-values ≤ 1.684, 
corresponding p-values ≥ .212). However, the two-way ANOVA for the VAS magnitude 
revealed a significant interaction between substance group and run (F(1,17) = 10.460, p = 
.005; see Figure 2). 
Post hoc comparisons for this interaction showed a higher VAS magnitude in the 
placebo (mean = 57.09, SD = 6.30) than in the naloxone group (mean = 68.25, SD = 12.56) 
for similarity judgments (p  = .023) but a comparable VAS magnitude between the naloxone 
(60.54, SD = 8.31) and placebo group (60.17, SD = 14.30) for dissimilarity judgments (p = 
.945). Moreover, while in the placebo group VAS magnitudes were higher for similarity than 
for dissimilarity judgments (p = .036), VAS magnitudes for similarity and dissimilarity in the 
naloxone group were not significant different from one another (p = .085). 
 
---------------------------------INSERT FIGURE 2 ABOUT HERE-------------------------------------- 
 
Reaction latencies: there were no significant main effects or interactions (all F-values ≤ 
1.716, corresponding p-values ≥ .208). 
 
Discussion 
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Healthy participants were administered a novel perceptual cognitive judgment task 
assessing visual similarity and dissimilarity. In a double-blind, naloxone, placebo-controlled 
between-subject design we aimed to investigate a role of endogenous opioids in “cognitive 
relatedness”. 
 
We focused on the hypothesis that a cognitive equivalent to social distance regulation might 
be conceptualized as “cognitive relatedness”, and could be dependent on mu-opioid receptor 
activity. 
In short, the results both support and contradict our original hypothesis. The kind of 
coherence perception interacted with naloxone administration. More specifically, the VAS 
magnitude of similarity judgments but not dissimilarity judgments of visual presented object 
pairs were more moderate (e.g. a shift towards low similarity) for participants in the naloxone 
than in the placebo group. Reaction latencies did not differ in the two groups. In addition, 
psychometrically assessed mood did not differ between the placebo and naloxone group. 
Therefore, the effects of altered VAS magnitudes are unlikely to simply reflect naloxone-
induced altered motor performance and/or motivation and thus did not confound the 
operationalization of the cognitive judgments.  
High similarity was perceived differently from low dissimilarity but only in the placebo, 
but not in the naloxone group. The VAS magnitude of similarity was more pronounced than 
that of dissimilarity. 
 
 We thus infer that the opioid antagonist naloxone decreased the “analogy criterion” in 
visual cognitive-affective judgments, but only when framed for similarity, but not for 
dissimilarity. This finding demonstrates a modulatory effect of naloxone on judgments of 
cognitive relatedness and suggests that some aspects of formal cognition, i.e. the readiness 
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to judge something as similar and simultaneously as dissimilar might be dependent on mu-
opioid receptor activity. 
Clearly, although we did not find psychometrically assessed mood differences between the 
placebo and naloxone group, further research needs to disentangle whether the altered 
cognitive strategies in similarity judgments are due to naloxone-induced changes in the 
affective system (i.e. a mildly detached or dysphoric mood) or are the result of a specific, 
opioid-associated cognitive focusing on formal stimulus properties perceived to be related to 
one another. This could be done through use of more elaborated and combined formally 
complex and affectively loaded visual stimuli and by showing an accentuation of similarity 
judgments under the influence of opioidergic agonists. Most insightful would be a replication 
of our approach using positron-emission tomography with [(11)C]carfentanil (Zubieta et al., 
2003) to measure possible cortical regional mu-opioid receptor availability in vivo. Indeed, a 
high density of mu-opioid receptors in the brains of macaque monkeys (Lewis et al., 1981, 
Wise and Herkenham, 1982) and similar findings in human subjects (Quirion and Pilapil, 
1991), has been found to be distributed along a gradient that increases in density along the 
ventral visual pathway and in association areas such as the parahippocampal cortex. 
One may dare to surmise that distinct biological systems are specifically involved in 
the neuronal generation of coherence perception. This type of perception, if not a human 
equivalent of “social emotions” in animals (Herman and Panksepp, 1978, Panksepp et al., 
1980, Panksepp, 2003), may arguably be at the heart of spotting similarities in objects, 
minds and intentions that surround an individual. Under this broad perspective, one further 
effect uncovered in the present study deserves to be mentioned. Judging two stimuli as 
highly similar in the similarity judgment run was no indicator of how dissimilar those same 
stimuli would be perceived in the dissimilarity judgment run. That is, the perception of 
relatedness, or “coherence perception”, is by no means a homogenous perceptual-cognitive 
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act. Rather, emphasis on resemblance and unity may principally differ from a focus on 
distinctive features of scene or social interaction. 
 
From a methodological point of view, classical self-report measures for affective 
states have cast doubt on the reliability of these measurements (e.g. Clark and Schober, 
1992, Tourangeau et al., 2000). Our novel task could thus provide a non-verbal, indirect, 
sensitive cognitive measure for the implicit study and quantification of subtle affective-
cognitive (51)[51][51][51] processes such as pain judgment and evaluative reasoning beyond 
the level of mere questionnaire data. To conclude, whether the glass is judged half-full or 
half-empty may (see Figure 3 for an illustrative ambigram) depend on the rater’s balancing of 
positive and negative affect. The former tends to promote cognitive, “relational processes”, 
whereas the latter may inhibit relational processing and narrow down the focus on stimulus-
specific processing (Clore and Palmer, 2008). 
 
-------------------------------------INSERT FIGURE 3 ABOUT HERE---------------------------------------- 
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Figure Legends 
 
 
Figure 1: Time course of the stimulations for the similarity judgment run (SJ) (A) and the 
dissimilarity judgment run (DJ) (B). After 750 ms (fixation of a central cross), a stimulus 
consisting of two horizontally placed meaningless geometric objects was bilaterally exposed 
for 150 ms (balanced for object side order). Subsequently, the degree of similarity or 
dissimilarity by clicking on the computerized VAS had to be indicated. In order to control the 
baseline mouse position, participants had to click on the fixation cross in the middle of the 
screen after each judgment (which elicited the next trial). Participants were instructed to 
respond as quickly and as intuitively as possible and to fixate their gaze on a cross in the 
center of the screen. 
 
Figure 2: VAS magnitude score (in percent) for the two substance groups (naloxone, 
placebo) and the two runs (SJR, DJR) (mean ± standard error). Because all participants 
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indicated mean VAS scores above 50%, the illustrated scale range has been adapted to be 
read from 50 to 75%. Asterisks (*) indicate significant post-hoc comparisons (*P < 0.05). 
 
Figure 3: Ambigram “Identical / Opposite” created by the American graphic designer Scott 
Kim in 1989. © Scott Kim, scottkim.com. 
 
 
 
